Maraat, Reggie Ann B.
HRN: 25-33-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/04/2024
07/14/2024
IV
500mg
Q6
Bacterial Meningitis
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Choice Wrong Choice
Overall appropriateness: No Wrong Choice